| Name | Title | Contact Details |
|---|
GHX is a software-as-a-service company that`s reducing the cost of doing business in healthcare by automating supply chain processes and improving visibility into the products used in patient care. We`ve built the GHX Global Network, the world`s largest community of healthcare trading partners, connecting supply chain, finance and clinical professionals with their suppliers. Our cloud-based technology makes it easier for customers to drive costs out of the healthcare supply chain. Since 2010, we`ve saved the healthcare industry $5+ billion. Today we`re expanding our solutions to further enhance data management and allow integration of clinical and business systems. The Industry We Serve Our focus is on the healthcare supply chain, through which hospitals and their suppliers buy and deliver the thousands of medical-surgical supplies that clinicians need to effectively care for patients. For most hospitals, supply chain costs are the second largest and fastest growing operational expense, so reining in these costs is imperative. Our Products and Services At the heart of GHX is the GHX Exchange, a platform that connects healthcare providers and suppliers so they can work together electronically. This helps lower costs and simplifies supply chain management by eliminating error-prone, manual order processes. GHX solutions include: • An open and neutral electronic trading exchange • Procurement and accounts payable automation • Content, contract and inventory management • Business intelligence and reporting • Standards enablement and data synchronization
Cellanyx has developed proprietary live tumor cell phenotypic biomarker tests to improve cancer risk-stratification and allow informed clinical decision making. The Companys unique approach provides quantitative and actionable information based on analysis of thousands of live tumor cells. The Companys tests employ a microfluidic platform combined with machine vision and machine learning approaches to analyze phenotypic morphological, biochemical and biophysical markers. Cellanyx has demonstrated initial clinical proof-of-concept with its lead phenotypic test in prostate cancer. The initial clinical proof-of-concept study was conducted to demonstrate improved risk stratification in men with low and intermediate Gleason grade (6 and 7) disease and reduce the number of repeat biopsies. Furthermore, analysis of field samples (away from the suspicious core) demonstrated the potential value of Cellanyx phenotypic test as it was able to analyze the tumor microenvironment conditions and predict expected adverse pathology from samples that were not taken from the suspicious core. These new findings from the Cellanyx prostate test are transformative as it will reduce the errors in diagnosing cancers early due to sampling heterogeneity of prostate biopsies.
To improve the health status of the communities we serve through compassionate, high quality, accessible and cost effective care. We value those who provide our care and those who receive our care. We accomplish this through partnership, dedication, service, quality and stewardship.
STS North America (Sterilizer Technical Specialists East) is a Chagrin Falls, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Tru Grit set out to craft a line of professional grade fitness products for those who refuse to quit. Our passion for fitness and innovation inspires our team to create fitness equipment that are professional grade at an affordable price. Our products ...